EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gypenoside XIII regulates lipid metabolism in HepG2 hepatocytes and ameliorates nonalcoholic steatohepatitis in mice

Shu-Chen Cheng, Chian-Jiun Liou iD, Ya-Xuan Wu, Kuo-Wei Yeh, Li-Chen Chen, Wen-Chung Huang iD

The Kaohsiung Journal of Medical Sciences · 2024

DOI: 10.1002/kjm2.12795 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2024. Verfasst von Shu-Chen Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chang Gung Memorial Hospital, Linkou, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gypenoside XIII is isolated from Gynostemma pentaphyllum (Thunb.) Makino. In mice, G. pentaphyllum extract and gypenoside LXXV have been shown to improve non‐alcoholic steatohepatitis (NASH). This study investigated whether gypenoside XIII can regulate lipid accumulation in fatty liver cells or attenuate NASH in mice. We used HepG2 hepatocytes to establish a fatty liver cell model using 0.5 mM oleic acid. Fatty liver cells were treated with different concentrations of gypenoside XIII to evaluate the molecular mechanisms of lipid metabolism. In addition, a methionine/choline‐deficient diet induced NASH in C57BL/6 mice, which were given 10 mg/kg gypenoside XIII by intraperitoneal injection. In fatty liver cells, gypenoside XIII effectively suppressed lipid accumulation and lipid peroxidation. Furthermore, gypenoside XIII significantly increased SIRT1 and AMPK phosphorylation to decrease acetyl‐CoA carboxylase phosphorylation, reducing fatty acid synthesis activity. Gypenoside XIII also decreased lipogenesis by suppressing sterol regulatory element‐binding protein 1c and fatty acid synthase production. Gypenoside XIII also increased lipolysis and fatty acid β‐oxidation by promoting adipose triglyceride lipase and carnitine palmitoyltransferase 1, respectively. In an animal model of NASH, gypenoside XIII effectively decreased the lipid vacuole size and number and reduced liver fibrosis and inflammation. These findings suggest that gypenoside XIII can regulate lipid metabolism in fatty liver cells and improve liver fibrosis in NASH mice. Therefore, gypenoside XIII has potential as a novel agent for the treatment of NASH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseMiceAnimalsLipid MetabolismGynostemmaMice, Inbred C57BLHepatocytesFatty AcidsLipidsLiver CirrhosisLiverPlant Extracts

Stichwörter der Autor:innen

gypenoside XIIIinflammationlipogenesislipolysisnon-alcoholic steatohepatitis

Substanzen

gypenosideFatty AcidsLipidsPlant Extracts

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Graduate Institute of Health Industry Technology, Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Taoyuan City, Taiwan.
  • Department of Nursing, Division of Basic Medical Sciences, Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Taoyuan City, Taiwan.
  • Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taoyuan City, Taiwan.
  • Department of Pediatrics, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation), New Taipei, Taiwan.

ORCID-Profile: Chian-Jiun Liou, Wen-Chung Huang

Förderung

  • Chang Gung Memorial Hospital, Linkou
  • National Science and Technology Council

Zitieren

APA

Cheng, S. C., Liou, C. J., Wu, Y. X., Yeh, K. W., Chen, L. C., & Huang, W. C. (2024). Gypenoside XIII regulates lipid metabolism in HepG2 hepatocytes and ameliorates nonalcoholic steatohepatitis in mice. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.12795

Vancouver

Cheng SC, Liou CJ, Wu YX, Yeh KW, Chen LC, Huang WC. Gypenoside XIII regulates lipid metabolism in HepG2 hepatocytes and ameliorates nonalcoholic steatohepatitis in mice. The Kaohsiung Journal of Medical Sciences. 2024. doi:10.1002/kjm2.12795

BibTeX
@article{Cheng2024,
  author = {Cheng, Shu-Chen and Liou, Chian-Jiun and Wu, Ya-Xuan and Yeh, Kuo-Wei and Chen, Li-Chen and Huang, Wen-Chung},
  title = {Gypenoside XIII regulates lipid metabolism in HepG2 hepatocytes and ameliorates nonalcoholic steatohepatitis in mice},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2024},
  doi = {10.1002/kjm2.12795}
}
Kostenlos starten →